Article: Kyphon Launches New Product for Balloon Kyphoplasty; Balloon Kyphoplasty Provides Significant Improvement in Quality of Life to Patients Suffering From Spinal Fractures Due to Osteoporosis.

SUNNYVALE, Calif., May 17 /PRNewswire/ -- Kyphon Inc., a global leader in minimally invasive spinal therapies, recently launched KyphX(R) HV-R(TM) Bone Cement, the first product on the market specifically indicated for treating spinal fractures caused by osteoporosis. The product was cleared by the United States Food & Drug Administration for use during kyphoplasty, a minimally invasive procedure that repairs spinal deformity due to osteoporotic fractures, significantly reducing back pain and improving patients' ability to return to activities of daily living.

"I am proud that Kyphon is able to provide patients the first product specifically indicated for ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!